Merck really hates its customers


Request:  Please subscribe to my feed.  Here is help for subscribing.

Tens of thousands of Americans have died after taking the painkiller Vioxx and its manufacturer Merck has been sued by their loved ones and also by those who suffered a heart attack or stroke but were lucky enough to survive.

It is still too early to say who is right about Vioxx – Merck that claims that it did not injure anyone or patients who have been hurt – but so far it is obvious that the victims are clearly losing against the might of a corporation that knows how to manipulate the legal system.

According to The New York Times, the company has spent more than a billion dollars on Vioxx litigation but all of it has gone to its lawyers. Not a single penny has been handed out to the victims. In each of the cases it has lost, the company has simply appealed. While almost everyone expects the company to eventually settle but for the time being the company is willing to fight it out to lower its liability.

And how much is its liability? It is too early to tell though it seems that Lehman Brothers has lowered the estimate to just $5 billion – my analysis which does not make an attempt at predicting the future puts it much higher. The Times analysis shows that most victims will die before they receive a trial or see a penny from the company.

What a great way to treat your customers?

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments

No comments yet.

Sorry, the comment form is closed at this time.